NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹161 Cr | ₹91 Cr | ₹45 Cr | ₹74 Cr | ₹104 Cr |
What is the latest Secured Loans ratio of NEULAND LABORATORIES ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹161 Cr |
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹74 Cr |
| Mar2022 | ₹104 Cr |
How is Secured Loans of NEULAND LABORATORIES Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹161 Cr | 77.40 | |
| Mar2025 | ₹91 Cr | 101.97 | |
| Mar2024 | ₹45 Cr | -39.50 | |
| Mar2023 | ₹74 Cr | -28.78 | |
| Mar2022 | ₹104 Cr | - | |
Compare Secured Loans of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹26,013.6 Cr | 2.3% | -5.4% | 14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2.3% |
-5.4% |
14.8% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses